Tuesday, May 24, 2016

SEC Reviewed Valeant's Use of 'Non-GAAP' Financial Measures

The SEC reviewed Valeant Pharmaceuticals’ use of adjusted “non-GAAP” financial measures, and criticized Valeant’s disclosures at one point as “potentially misleading,” according to documents.

from WSJ.com: US Business http://ift.tt/1OUQmeB
via IFTTT

No comments:

Post a Comment